EMT can increase migration and invasion potential of tumor cells by increasing expression of mesenchymal biomarkers, N-cadherin, vimentin and fibronectin and decreasing epithelial cell phenotype biomarkers like E-cadherin (Cano et al., 2000). Here, CDH2 is linked to neoplasm.